Therapeutics Company Announces Royalty Sale For Up To $31.5 Million
Aclaris Therapeutics Announces Sale of OLUMIANT® Royalties and Milestones to OMERS Life Sciences for Up to $31.5 Million.
Disclaimer: The following article is for informational purposes only and does not constitute financial advice or a solicitation to invest in any company mentioned within. Readers are encouraged to conduct their own research and seek advice from licensed professionals before making any investment decisions.
Real-time information is…